Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a pseudogene related to the galectin gene family (specifically galectin-9) and does not encode a functional protein product. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition and often accumulate disabling mutations[1]. There is no known role for this pseudogene as a molecular target, receptor, or relevant entity for drug discovery or therapeutic development. Key clarification: Unlike "lectin, galactoside-binding, soluble, 3 binding protein" (LGALS3BP), which is an established protein with roles in immunity and cancer progression[2][3][4], the "lectin, galactoside-binding, soluble, 9 pseudogene" is non-coding and not recognized as a biological target[1]. If you are seeking information about galectin-9 (a different, functional member of the family), please clarify, as this entry is a pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lectin, galactoside-binding, soluble, 9 pseudogene (LGALS9 pseudogene).